How experimental drug remdesivir moved from back shelf to best hope for treating COVID-19

remdesivir was initially investigated as a treatment for Ebola |

Email not displaying correctly? View it in your browser.

Subscribe to TIME magazine WHAT TO KNOW NOW LISTEN How Experimental Drug Remdesivir Moved From Back Shelf to Best Hope for Treating COVID-19 Remdesivir could be the first real treatment for COVID-19 that finally gives humans even a slight upper hand against the microbe. Column: You Don't Have to Be Hopeful to Fight for a Better Future This crisis has been a reminder of all the ways we can connect with like-minded individuals even when we can't meet up, writes climate activist Isabelle Axelsson Hong Kong Restaurants Are Going to Great Lengths to Protect Diners. Here's What the U.S. Could Learn Hong Kong hasn't recorded a cluster of coronavirus cases related to restaurants since late March. Here's how eateries are protecting customers Column: What Will TV Look Like After the Pandemic? The future of real-time TV has looked bleak for quite some time. But, for many reasons, coronavirus appears to be accelerating the decline, writes Judy Berman Watch the Class of 2020 Share What It’s Like to Graduate in the COVID-19 Pandemic WHO Suspends Study of Hydroxychloroquine as COVID-19 Treatment to Review Safety Concerns ‘Water Is PPE.’ Matt Damon and Gary White Explain Why Clean Water Is Crucial To Fighting Coronavirus In 1968, These Activists Coined the Term ‘Asian American’—And Helped Shape Decades of Advocacy How to Rethink Your Investments When COVID-19 Uncertainty Reigns Casino Tycoon Stanley Ho, Who Transformed Macau into the 'Las Vegas of Asia,' Dies at 98 What to Say to the Class of 2020 Amid the Coronavirus Crisis NASA Urge Spectators to Stay Away From First U.S. Astronaut Launch in 9 Years Because of Coronavirus To Unsubscribe You have received this e-mail because you are subscribed to this newsletter from TIME.com. Unsubscribe here. Update Email Click here to update your email address. Privacy Policy Please read our Privacy Policy, or copy and paste this link into your browser: https://time.com/privacy TIME may receive compensation for some links to products and services on this website. Offers may be subject to change without notice. For questions about your print or digital magazine subscription, please contact: TIME USA, LLC 3 Bryant Park New York, NY 10036 TIMcustserv@cdsfulfillment.com For feedback about this newsletter: Please contact thebrief@time.com Connect with TIME